natgillin/translations-raw huggingface dataset:
Breelib is a small handheld, battery-powered, breath activated, vibrating mesh technology system.
Breelib je mali, ručni, nebulizatorski sustav s baterijskom napajanjem s tehnologijom vibrirajuće mrežice koji se aktivira udahom.
− Conditions where the effects of Ventavis on platelets might increase the risk of haemorrhage
- Stanja pri kojima učinci lijeka Ventavis na trombocite mogu povećati rizik od krvarenja (npr.
In the iloprost group the NYHA class was improved in 26% of patients (placebo: 15%) (p = 0.032), unchanged in 67.7% of patients (placebo: 76%) and deteriorated in 6.3% of patients (placebo: 9%).
(p = 0,032), u 67,7% bolesnika nije bilo promjene (placebo: 76%), dok je u 6,3% bolesnika došlo do pogoršanja stanja (placebo: 9%).
Ventavis nebuliser solution should not come into contact with skin and eyes; oral ingestion of Ventavis solution should be avoided.
Kontakt s kožom i očima, ingestija Ventavis otopina za nebulizator ne smije doći u kontakt s kožom ni očima; mora se izbjeći ingestija otopine Ventavis.
• 168 (4x42) ampoules
• 168 (4 x 42) ampula
Data with intravenously administered iloprost indicated that the elimination is reduced in patients with hepatic dysfunction and in patients with renal failure requiring dialysis (see section 5.2).
Podaci o intravenskoj primjeni iloprosta ukazuju na to da je eliminacija smanjena u bolesnika s jetrenom disfunkcijom i u bolesnika sa zatajenjem bubrega na dijalizi (vidjeti dio 5.2).
Ventavis 20 microgram/ml is double the concentration of Ventavis 10 microgram/ml.
Ventavis 20 mikrograma/ml ima dvostruku koncentraciju u odnosu na Ventavis 10 mikrograma/ml.
• 90 ampoules
• 90 ampula
The haemodynamics observed suggest an acute response with preferential effect of inhaled treatment on the pulmonary vessels.
Primijećeni hemodinamički podaci upućuju na akutni odgovor uz pretežiti učinak liječenja inhaliranjem na plućne žile.
If you cannot tolerate inhalation of Ventavis 20 microgram/ml talk to your doctor who may decide that you should take Ventavis 10 microgram/ml (1 ml ampoule).
Ako ne možete podnijeti inhalaciju lijekaVentavis 20 mikrograma/ml obratite se svom liječniku koji može odlučiti da trebate uzimati Ventavis 10 mikrograma/ml (ampula od 1 ml).
To obtain the optimal droplet size for the administration of Ventavis 10 microgram/ml nebuliser solution the green baffle plate should be used.
Da bi se postigla optimalna veličina kapljica za primjenu Ventavis 10 mikrograma/ml otopine za nebulizator, potrebno je koristiti zelenu ploču.
Part of a multipack containing 300 ampoules with 2 ml.
Dio višestrukog pakiranja koje sadrži 300 ampula s 2 ml.
Part of a multipack containing 90 ampoules with 2 ml.
Dio višestrukog pakiranja koje sadrži 90 ampula s 2 ml.
• Ventavis 20 microgram/ml nebuliser solution is inhaled using the nebulisers your doctor prescribed (either the Breelib or the I-Neb AAD nebuliser).
• Ventavis 20 mikrograma/ml otopina za nebulizator inhalira se pomoću nebulizatora kojeg Vam je propisao liječnik (Breelib ili I-Neb AAD nebulizator).
Pulmonary veno-occlusive disease
Venookluzivna bolest pluća
Patients stabilised on one nebuliser should not switch to another nebuliser without close supervision by the treating doctor as different nebulisers have been shown to produce aerosols with slightly different physical characteristics and may have faster delivery of the solution (see section 5.2 of the Summary of Product Characteristics).
Bolesnici stabilizirani na jednom nebulizatoru ne bi smjeli prelaziti na korištenje drugog nebulizatora bez pomnog nadzora svog liječnika jer je dokazano da različiti nebulizatori stvaraju aerosole čija se fizička svojstva blago razlikuju i koji mogu brže isporučiti otopinu (vidjeti dio 5.2 sažetka opisa svojstava lijeka).
Pharmacokinetics of iloprost were investigated in a randomised, crossover study with 27 patients, stable on Ventavis 10 microgram/ml inhaled with I-Neb, following inhalation of single doses of 2.5 or 5 microgram iloprost using the Breelib or the I-Neb AAD nebuliser.
Farmakokinetika iloprosta ispitivana je u randomiziranom križnom ispitivanju na 27 bolesnika stabilnih na lijeku Ventavis 10 mikrograma/ml inhaliranom s I-Neb nebulizatorom, nakon inhalacije jednokratnih doza od 2,5 ili 5 mikrograma iloprosta pomoću nebulizatora Breelib ili I-Neb AAD.
Hypotension, an increase of blood pressure, bradycardia or tachycardia, vomiting, diarrhoea and limb pain might also be possible.
Mogući su također i hipotenzija, povišeni krvni tlak, bradikardija ili tahikardija, povraćanje, proljev te bolovi u udovima.
Bayer Oy Puh/Tel: +358 20 785 21
Puh/Tel: +358 20 785 21
Comparable systemic exposures (AUC (0-tlast)) and approximately 30% higher maximum serum concentrations (Cmax) were found following inhalation of Ventavis 20 microgram/ml compared to Ventavis 10 microgram/ml which was in line with the observed shorter inhalation time using Ventavis 20 microgram/ml.
Zabilježene su usporedive sistemske izloženosti (AUC [0-tlast])) i približno 30% više maksimalne koncentracije u serumu (Cmax) nakon inhalacije lijeka Ventavis 20 mikrograma/ml u odnosu na Ventavis 10 mikrograma/ml, što je bilo u skladu s opaženim kraćim trajanjem inhalacije kad se primjenjivao Ventavis 20 mikrograma/ml.
Your doctor will supervise your treatment when you start using the Breelib nebuliser to ensure that you tolerate dose and speed of inhalation well.
Na početku korištenja nebulizatora Breelib, liječnik će nadzirati Vaše liječenje kako bi se uvjerio da dobro podnosite dozu i brzinu inhalacije.
The risk of bleeding may be increased in patients when inhibitors of platelet aggregation or anticoagulants are given at the same time (see also section 2).
Rizik od krvarenja može biti povećan u bolesnika koji istodobno uzimaju i inhibitore agregacije trombocita ili antikoagulanse (pogledajte i dio 2.).
For administration with the Breelib or the I-Neb.
Za primjenu pomoću nebulizatora Breelib ili I-Neb.
Diarrhoea Vomiting Mouth and tongue irritation including pain
Poremećaji probavnog sustava mučnina proljev povraćanje iritacija usta i jezika uključujući i bol disgeuzija
• 100 ampoules
• 100 ampula
Poligono Industrial Santa Rosa s/n 28806 Alcalá de Henares Madrid
28806 Alcalá de Henares
• pain in jaw/spasm of the jaw muscles (trismus)
• mučnina • bol u čeljusti / grč mišića čeljusti (trizmus)
After each inhalation session, any solution remaining in the nebuliser should be discarded.
Nakon svake inhalacije, ostatak otopine u nebulizatoru mora se baciti.
Excipients: trometamol, ethanol 96%, sodium chloride, hydrochloric acid (for pH adjustment), water for injections.
Pomoćne tvari: trometamol, etanol 96%, natrijev klorid, kloridna kiselina (za podešavanje pH), voda za injekcije.
The Mass Median Aerodynamic Diameter (MMAD) of the aerosol measured using I-Neb nebulising systems equipped with power level 10 disc was similar between Ventavis 20 microgram/ml (golden programme) and Ventavis 10 microgram/ml (purple programme) nebuliser solutions (i.e.: around 2 micrometres) but with faster delivery when using Ventavis 20 microgram/ml.
Medijan mase aerodinamičkog promjera (MMAD) aerosola izmjeren pri upotrebi I-Neb nebulizatorskog sustava opremljenog diskom snage razine 10 bio je sličan za Ventavis 20 mikrograma/ml (zlatni program) i Ventavis 10 mikrograma/ml (ljubičasti program) otopine za nebulizator (tj. MMAD je iznosio oko 2 mikrometra), ali s bržim isporučivanjem kada se koristi Ventavis 20 mikrograma/ml.
mouthpiece and 1 medication chamber).
1 nastavak za usta i 1 komoru za lijek).
In the iloprost group, the median daily inhaled dose was 30 microgram (range 12.5 to 45 microgram/day).
30 mikrograma (raspon od 12,5 do 45 mikrograma dnevno).
Be sure to ventilate or air the room in which you have taken your Ventavis treatment.
Svakako ventilirajte ili prozračite prostoriju u kojoj ste primijenili Ventavis.
• Venta-Neb nebuliser (2 ml ampoule with white and pink rings)
• Nebulizator Venta-Neb (ampula od 2 ml s bijelim i ružičastim prstenom)
To minimise accidental exposure, it is recommended to keep the room well ventilated.
Kako bi se nehotično izlaganje svelo na najmanju mjeru, preporučuje se dobro prozračivati prostoriju.
Τηλ: +30 210 61 87 500
Bayer Ελλάς ΑΒΕΕ Τηλ: +30 210 61 87 500
• 30 ampoules
• 30 ampula
If you are unable to tolerate the 5 microgram dose, the dose should be reduced to 2.5 microgram.
Ako ne možete podnijeti dozu od 5 mikrograma, dozu je potrebno smanjiti na 2,5 mikrograma.
Ventavis should only be initiated and monitored by a physician experienced in the treatment of pulmonary hypertension.
Liječenje lijekom Ventavis smije započeti i pratiti samo liječnik s iskustvom u liječenju plućne hipertenzije.
Bronchospasm* (see section 4.4) / Wheezing
(vidjeti dio 4.4) / piskanje
• fast heartbeat (tachycardia)
• ubrzani otkucaji srca (tahikardija)
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS AMPOULE WITH 1 ML
PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE AMPULA S 1 ML
• Bronchospasm (sudden constriction of the muscles in the walls of the small airways) and wheezing (see also section 2 “Warnings and precautions”)
Nepoznato (ne može se procijeniti iz dostupnih podataka): • Bronhospazam (iznenadno stezanje mišića u stijenkama malih dišnih putova) i piskanje pri disanju (pogledajte također dio 2. "Upozorenja i mjere opreza").
Just before you start to inhale, break the glass ampoule and pour the solution into the medication chamber following the instructions for use of the nebuliser.
Neposredno prije početka inhalacije, prelomite staklenu ampulu i sav njezin sadržaj izlijte u komoru za lijek slijedeći upute za uporabu nebulizatora.
It cannot be excluded that this is also relevant to humans on prolonged Ventavis therapy.
Ne može se isključiti jednak učinak u ljudi u slučaju dugotrajnog liječenja lijekom Ventavis.
To obtain the optimal droplet size for the administration of Ventavis the green baffle plate should be used.
Da bi se postigla optimalna veličina kapljica za primjenu lijeka Ventavis, potrebno je koristiti zelenu ploču.
Syncope is a common symptom of the disease itself and can also occur under therapy.
Sinkopa je uobičajeni simptom same bolesti, a može se pojaviti i tijekom liječenja.
In a study with intravenous infusion of iloprost, patients with end-stage renal failure undergoing intermittent dialysis treatment are shown to have a significantly lower clearance (mean CL = 5 ± 2 ml/minute/kg) than that observed in patients with renal failure not undergoing intermittent dialysis treatment (mean CL = 18 ± 2 ml/minute/kg).
U ispitivanju s intravenskom infuzijom iloprosta u bolesnika sa zatajenjem bubrega u završnoj fazi na intermitentnoj dijalizi uočen je značajno niži klirens (srednja vrijednost CL = 5 ± 2 ml/minuta/kg) od onog koji je uočen u bolesnika sa zatajenjem bubrega koji se ne podvrgavaju intermitentnoj dijalizi
Tachycardia Palpitations
Srčani poremećaji tahikardija palpitacije
• hypersensitivity (i.e. allergy)
• smanjen broj trombocita (trombocitopenija) • preosjetljivost (tj. alergija)
The use of Ventavis is not recommended in patients with unstable pulmonary hypertension, with advanced right heart failure.
4.4 Posebna upozorenja i mjere opreza pri uporabi Upotreba lijeka Ventavis ne preporučuje se bolesnicima s nestabilnom plućnom hipertenzijom s uznapredovalim zatajenjem desne strane srca.
Estimated inhalation time
Procijenjeno trajanje inhalacije
Multipack containing 90 (3x30) or 300 (10x30) ampoules.
Višestruko pakiranje sadrži 90 (3 x 30) ili 300 (10 x 30) ampula.
Patients initiating Ventavis treatment or switching from an alternative device to Breelib should be closely supervised by the treating physician to ensure that dose and speed of inhalation are well tolerated.
Potreban je pomni nadzor bolesnika koji započinju liječenje lijekom Ventavis ili prelaze s drugog nebulizatora na Breelib od strane nadležnog liječnika kako bi se osiguralo da se doza i brzina inhalacije dobro podnose.
Ampoules with 1 ml nebuliser solution (for the use of Breelib or I-Neb AAD): Packages containing:
Ampule s 1 ml otopine za nebulizator (za primjenu pomoću uređaja Breelib ili I-Neb AAD): Pakiranja sadrže:
Your doctor will advise you.
to će Vas uputiti Vaš liječnik.
If inhalation with Ventavis 10 microgram/ml is well tolerated, the dose should be increased by using Ventavis 20 microgram/ml.
Ako se inhalacija lijeka Ventavis 10 mikrograma/ml dobro podnosi, dozu je potrebno povećati primjenom lijeka Ventavis 20 mikrograma/ml.
• stop the inhalation session
• prekinite s inhalacijom
In case of poor tolerability of Ventavis 20 microgram/ml, the dose should be reduced by using 1 ml ampoule of Ventavis 10 microgram/ml (see section 4.4).
U slučaju slabog podnošenja lijeka Ventavis 20 mikrograma/ml, doza se mora smanjiti primjenom ampule od 1 ml lijeka Ventavis 10 mikrograma/ml (vidjeti dio 4.4).
6.5 Nature and contents of container Ventavis 10 microgram/ml nebuliser solution
6.5 Vrsta i sadržaj spremnika Ventavis 10 mikrograma/ml otopina za nebulizator
• I-Neb AAD nebuliser (1 ml ampoule with white and yellow rings)
• Nebulizator I-Neb AAD (ampula od 1 ml s bijelim i žutim prstenom)
Bayer AB Tel: +46 (0) 8 580 223 00
Tel: +46 (0) 8 580 223 00
Just before you start to inhale, take the yellow-red colour coded ampoule of Ventavis 20 microgram/ml, break the glass ampoule and pour the complete contents of 1 ml into the nebuliser medication golden chamber.
Neposredno prije početka inhalacije, uzmite ampulu lijeka Ventavis 20 mikrograma/ml označenu žutom i crvenom bojom, prelomite staklenu ampulu i sav njezin sadržaj od 1 ml izlijte u komoru za lijek zlatne boje u nebulizatoru.
Data with intravenously administered iloprost indicated that the elimination is reduced in patients with renal failure requiring dialysis.
Podaci o intravenskoj administraciji iloprosta ukazuju da je u bolesnika sa zatajenjem bubrega na dijalizi eliminacija smanjena.
Bayer OÜ Tel: +372 655 8565
Tel: +372 655 8565
Serum glucose levels
Razine glukoze u serumu
The I-Neb AAD System is a portable, hand-held, vibrating mesh technology nebuliser system.
Sustav I-Neb AAD je prijenosni ručni nebulizatorski sustav s tehnologijom vibrirajuće mrežice.
Hepatic impairment Iloprost elimination is reduced in patients with hepatic dysfunction (see section 5.2).
U bolesnika s poremećenom funkcijom jetre eliminacija iloprosta je smanjena (vidjeti dio 5.2).
In case of interruption of Ventavis therapy, the risk of rebound effect is not formally excluded.
Rizik od pogoršanja simptoma bolesti u slučaju prekida liječenja lijekom Ventavis nije službeno isključen.
Keep this medicine out of the sight and reach of children.
Kako čuvati Ventavis Lijek čuvajte izvan pogleda i dohvata djece.
In case of poor tolerability of the 5 microgram dose, the dose should be reduced to 2.5 microgram iloprost.
U slučaju slabe podnošljivosti doze od 5 mikrograma, doza se mora smanjiti na 2,5 mikrograma iloprosta.
Ampoule coloured rings
Ampula / obojeni prstenovi
Newborns, infants and pregnant women should not be subjected to Ventavis in the room air.
Novorođenčad, dojenčad i trudnice ne smiju biti izloženi lijeku Ventavis koji se nalazi u zraku u prostoriji.
Ampoules with 1 ml nebuliser solution (for the use of Breelib or I-Neb AAD):
Ampule s 1 ml otopine za nebulizator (za primjenu pomoću uređaja Breelib ili I-Neb AAD):
5 mcg
5 µg
Pharmacokinetics under the specific study conditions of extended inhalation time, were investigated in a randomised, crossover study with 19 healthy adult men following inhalation of single doses of Ventavis 10 microgram/ml and Ventavis 20 microgram/ml (dose of 5 microgram iloprost at the mouthpiece) using the I-Neb.
Farmakokinetika u posebnim uvjetima ispitivanja koji su uključivali produljeno trajanje inhalacije ispitana je u randomiziranom križnom ispitivanju na 19 zdravih odraslih muškaraca nakon inhalacije jednokratnih doza lijeka Ventavis 10 mikrograma/ml i Ventavis 20 mikrograma/ml (doza od
The baseline 6-minute walk test values reflected a moderate exercise limitation: in the iloprost group the mean was 332 metres (median value: 340 metres) and in the placebo group the mean was 315 metres (median value: 321 metres).
Vrijednosti početnog testa 6-minutnog hoda ukazivale su na umjereno ograničenje tjelesnih aktivnosti: u skupini koja je primala iloprost prosjek je iznosio 332 metra (medijan vrijednosti:
Your doctor will supervise your treatment if switching from Ventavis 10 microgram /ml to Ventavis 20 microgram/ml to monitor how well you tolerate the higher concentration.
Ako ste prebačeni s lijeka Ventavis 10 mikrograma/ml na Ventavis 20 mikrograma/ml, liječnik će nadgledati Vaše liječenje da bi pratio koliko dobro podnosite višu koncentraciju.
Venta-Neb prompts the patient to inhale by an optical and an acoustic signal.
Venta-Neb bolesniku daje vizualni i zvučni signal za početak inhalacije.
Venta-Neb, a portable ultrasonic battery-powered nebuliser, has also been shown to be suitable for the administration of Ventavis 10 microgram/ml.
Venta-Neb, prijenosni ultrazvučni nebulizator s baterijskim napajanjem pokazao se prikladnim za primjenu lijeka Ventavis 10 mikrograma/ml.
Newborns, infants and pregnant women should not be in the same room while you are inhaling Ventavis.
Novorođenčad, dojenčad i trudnice ne smiju biti u istoj prostoriji dok Vi inhalirate Ventavis.
The ampoules containing 2 ml are marked with two coloured rings (white - pink).
Ampule koje sadrže 2 ml označene su s dva prstena u boji (bijeli - ružičasti).
Since the I-Neb AAD system can be used for Ventavis 10 microgram/ml and Ventavis 20 microgram/ml, the table below provides a summary of the user instructions of the I-Neb for the 2 concentrations of Ventavis:
Budući da se sustav I-Neb AAD može koristiti s lijekom Ventavis 10 mikrograma/ml i Ventavis 20 mikrograma/ml, donja tablica donosi sažetak uputa za korisnike za I-Neb za obje koncentracije lijeka Ventavis:
In particular, newborns, infants and pregnant women should not be in the same room while you are inhaling Ventavis.
Osobito, novorođenčad, dojenčad i trudnice ne smiju biti u istoj prostoriji dok inhalirate Ventavis.
Syncope is a common symptom of the disease itself, but can also occur under therapy.
Sinkopa je čest simptom same bolesti, ali može se pojaviti i tijekom liječenja.
Care should be exercised during initiation of therapy until any effects on the individual have been determined.
Na početku liječenja, dok se ne ustanove učinci na osobu, potrebno je primjenjivati mjere opreza.
• Ventavis 10 microgram/ml:
• Ventavis 10 mikrograma/ml:
Venta-Neb, a portable ultrasonic battery-powered nebuliser, has been shown to be suitable for the administration of Ventavis 10 microgram/ml nebuliser solution (2 ml ampoule).
Venta-Neb, prijenosni ultrazvučni nebulizator s baterijskim napajanjem pokazao se prikladnim za primjenu Ventavis 10 mikrograma/ml otopine za nebulizator (ampula od 2 ml).
At initiation of Ventavis treatment or if the patient is switched from an alternative device, the first inhalation should be made with 1 ml ampoule of Ventavis 10 microgram/ml (see section 4.4).
Na početku liječenja lijekom Ventavis ili ako bolesnik prelazi s uporabe drugog uređaja na Breelib, prva inhalacija mora se provesti s ampulom od 1 ml lijeka Ventavis 10 mikrograma/ml (vidjeti dio 4.4).
Ventavis 10 microgram/ml nebuliser solution (1 ml ampoule) delivers 2.5 microgram and Ventavis 20 microgram/ml nebuliser solution delivers 5 microgram at the mouthpiece of the Breelib nebuliser.
Ventavis 10 mikrograma/ml (ampula od 1 ml) otopina za nebulizator isporučuje 2,5 mikrograma, a Ventavis 20 mikrograma/ml otopina za nebulizator isporučuje 5 mikrograma u nastavku za usta Breelib nebulizatora.
How to store Ventavis
Kako primjenjivati Ventavis
PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML CO-PACKED WITH BREELIB CONSUMABLES SET
PAKIRANJE S 42 AMPULE U KARTONSKOJ KUTIJI SA 168 (4 x 42) AMPULA S 1 ML PAKIRANJE S 42 AMPULE U KARTONSKOJ KUTIJI SA 168 (4 x 42) AMPULA S 1 ML PAKIRANIH ZAJEDNO SA ZAMJENSKIM
• pain when swallowing (pharyngolaryngeal irritation)
• bol prilikom gutanja (iritacija ždrijela i grkljana)
The measured MMAD of the aerosol droplets was 2.6 micrometres.
Izmjereni medijan mase aerodinamičkog promjera kapljica aerosola iznosio je 2,6 mikrometara.
SIA Bayer Tel: +371 67 84 55 63
Tel: +371 67 84 55 63
Symptoms can be flushing or reddening of the face.
Simptomi mogu biti crvenilo praćeno osjećajem vrućine ili samo crvenilo lica.
For administration with the Venta-Neb.
Za primjenu pomoću nebulizatora Venta-Neb.
If you tolerate this dose well, your next inhalation will be with Ventavis 20 microgram/ml (ampoule with yellow and red rings).
Ako dobro podnosite tu dozu, pri sljedećoj inhalaciji ćete uzeti Ventavis od 20 mikrograma/ml (ampula sa žutim i crvenim prstenom).
What Ventavis is used for
Što je Ventavis i za što se koristi
Since the I-Neb AAD nebuliser can be used for Ventavis 10 microgram/ml and Ventavis 20 microgram/ ml, the table below provides a summary of the user instructions of the I-Neb for the 2 concentrations of Ventavis:
Budući da se I-Neb AAD nebulizator može koristiti s lijekom Ventavis 10 mikrograma/ml i Ventavis 20 mikrograma/ml, donja tablica prikazuje sažetak uputa za korisnike za I-Neb za obje koncentracije lijeka Ventavis:
Depending on your individual needs, Ventavis can be used for long term treatment.
Ventavis se može koristiti za dugotrajno liječenje ovisno o Vašim osobnim potrebama.
A mean increase in the 6-minute walk test of 44.7 metres from a baseline mean value of 329 metres vs. a change of -7.4 metres from a baseline mean value of 324 metres in the placebo group (no data imputation for death or missing values) was observed in the subgroup of 49 patients with primary pulmonary hypertension receiving treatment of inhaled iloprost for 12 weeks (46 patients in the placebo group).
U podskupini od 49 bolesnika s primarnom plućnom hipertenzijom koji su 12 tjedana liječeni inhaliranim iloprostom (46 bolesnika u skupini koja je primala placebo) uočeno je prosječno povećanje rezultata testa 6-minutnog hoda od 44,7 metara u odnosu na početnu prosječnu vrijednost od 329 metara, dok je u skupini koja je primala placebo uočena promjena od -7,4 metara u odnosu na početnu izmjerenu vrijednost od 324 metra (bez korekcije podataka za smrtne ishode ili nedostajuće vrijednosti).
Ventavis 10 microgram/ml is provided in colourless ampoules, containing either 1 ml or 2 ml nebuliser solution.
Ventavis 10 mikrograma/ml je dostupan u bezbojnim ampulama koje sadrže ili 1 ml ili 2 ml otopine za nebulizator.
Part of a multipack containing 168 (4 x 42) ampoules with 1 ml.
Dio višestrukog pakiranja koje sadrži 168 (4 x 42) ampula s 1 ml.
For details refer to the instruction manual of the Venta-Neb nebuliser.
Pojedinosti potražite u uputama za uporabu za nebulizator Venta-Neb.
As you repeatedly experience extended inhalation treatment times with Ventavis 10 microgram/ml (1 ml ampoule with white and yellow rings), your doctor decided to switch to Ventavis 20 microgram/ml.
Budući da Vam je trajanje inhalacijskog liječenja lijekom Ventavis 10 mikrograma/ml (ampula od 1 ml s bijelim i žutim prstenom) u više navrata bilo produljeno, liječnik Vas je odlučio prebaciti na
No studies to investigate the metabolism of iloprost were performed following inhalation of Ventavis.
Nakon inhalacije lijeka Ventavis nisu provedena ispitivanja metabolizma iloprosta.
Ventavis is a clear, colourless to slightly yellowish nebuliser solution for inhalation with the Breelib or the I-Neb nebuliser.
Kako Ventavis izgleda i sadržaj pakiranja: Ventavis je bistra, bezbojna do blago žućkasta otopina za nebulizator namijenjena za inhalaciju pomoću Breelib ili I-Neb nebulizatora.
Peripheral oedema is a very common symptom of the disease itself, but can also occur under therapy.
Periferni edem vrlo je čest simptom same bolesti, ali može se pojaviti i tijekom liječenja.
• Breelib nebuliser
• Nebulizator Breelib